# A Clinical Study to Assess the Safety of a New Influenza Vaccine

> **NCT01104493** · PHASE4 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 300 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Monovalent Frozen FluMist®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01104493
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2011-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104493, "A Clinical Study to Assess the Safety of a New Influenza Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01104493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*